Poor Adherence to National Clinical Management Guidelines: A Population-Based, Cross-Sectional Study of the Surgical Management of Melanoma in New South Wales, Australia-Reference-Cited by-同舟云学术

Poor Adherence to National Clinical Management Guidelines: A Population-Based, Cross-Sectional Study of the Surgical Management of Melanoma in New South Wales, Australia

Published:2017-05-25 Issue:8 Volume:24 Page:2080-2088
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Varey Alexander H. R.,Madronio Christine M.,Cust Anne E.,Goumas Chris,Mann Graham J.,Armstrong Bruce K.,Scolyer Richard A.,Curtin Austin M.,Thompson John F.

Funder

Cancer Institute NSW

National Health and Medical Research Council

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/article/10.1245/s10434-017-5890-7/fulltext.html

Reference19 articles.

1. World Health Organization. Ultraviolet radiation and the INTERSUN Programme. 2015. http://www.who.int/uv/faq/skincancer/en/index1.html . Accessed 5 May 2015.

2. Australian Institute of Health and Welfare. Cancer in Australia: an overview 2012 (online version). 2015. http://www.aihw.gov.au/cancer/cancer-in-australia-overview-2012/data-at-a-glance/ . Accessed 5 May 2015.

3. Cancer Research UK. Cancer incidence for common cancers. 2015. http://www.cancerresearchuk.org/cancer-info/cancerstats/incidence/commoncancers/#Twenty .

4. National Health and Medical Research Council. Clinical practice guidelines for the management of melanoma in Australia and New Zealand. 2008. https://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/cp111.pdf . Accessed 6 May 2015.

5. Pflugfelder A, Kochs C, Blum A, Capellaro M, Czeschik C, Dettenborn T, et al. Malignant melanoma S3-guideline “diagnosis, therapy and follow-up of melanoma”. J Dtsch Dermatol Gas. 2013;11:1–116.

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator;Journal of Clinical Oncology;2024-04-01

2. Primary Cutaneous Melanoma—Management in 2024;Journal of Clinical Medicine;2024-03-11

3. Lymphatic expression of the proliferation marker Ki67 is linked to sentinel node positivity, recurrence and mortality in primary cutaneous melanoma;Experimental Dermatology;2024-03

4. BRAF-Mutated Melanoma Journey in Latin America: Expert Recommendations From Diagnosis to Treatment;Cancer Control;2024-01

5. A retrospective study of sentinel lymph node biopsy for skin cancer in Japan: Comparison with breast cancer and evaluation of factors related to its use;Cancer Medicine;2023-10-30